NDONOVO THERAPEUTICS INC (ENDV) earnings
Quarterly and annual ENDV reports and results, each read against the price at its own news timestamp. Back to the ENDV overview →
3 measured ENDV earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q ENDONOVO THERAPEUTICS, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +0.81% | |
| Form 10-Q/A ENDONOVO THERAPEUTICS, For: Sep 30 | SEC filing · Form 10-Q | — | +7.14% | |
| Form NT 10-Q ENDONOVO THERAPEUTICS, For: Sep 30 | SEC filing · Form NT | — | +0.00% |
Keep exploring
More ENDV: analyst actions → · SEC filings → · ENDV overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| SYSMEX CORP UNSP/ASDR (SSMXY) | 13 | +0.19% | 54% |
| ABCAM PLC (ABCZY) | 12 | 0.00% | 20% |
| OTSUKA HOLDINGS CO LTD (OTSKF) | 12 | +0.11% | 100% |
| PROTECT PHARMS CORP (PRTT) | 12 | 0.00% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.